Although CABG in patients with PXE has been reported previously, very few of these studies involve the use of arterial grafts in PXE patients. Herein, we present a patient with longstanding PXE who underwent coronary artery bypass surgery via the left internal mammary artery (LIMA).
Cardiac catheterization demonstrated severe CAD. Both the left anterior descending (LAD) and the right coronary arteries (RCA) were totally occluded, and the first diagonal branch was also severely involved. Because of the possibility of using it as a graft, the LIMA was also visualized during the angiography. Its diameter was normal without any calcification or plaque obliterating the vessel lumen. An echocardiographic examination was unremarkable except for inferior wall akinesia with an ejection fraction (EF) of 51%.
Before the operation, a dermatologist and an ophthalmologist evaluated the patient and found only two skin lesions at the medial corner of the upper palpebra bilaterally. In addition, a funduscopic examination was normal except for atrophic scar images in the macula of both eyes. After examining these results, the patient was scheduled for CABG.
Following a median sternotomy, the LIMA and saphenous vein were harvested. The LIMA was examined for plaque and calcification, and the flow was measured. No plaque was observed, and the LIMA flow was 154 ml/minute, which was accepted as sufficient. The distal part of the LIMA was taken for histopathologic examination before the LAD anastomosis, and degeneration of the elastic lamina of the arterial wall and dissection of the media layer were observed (Figure 1). The patient had CABG with cardiopulmonary bypass (CPB) and hypothermic cardioplegic arrest. At first, the saphenous vein grafts were anastomosed to the posterior descending artery and the first diagonal branch. Then the LIMALAD anastomosis was performed. Following proximal anastomosis, the patient was weaned off of the CPB. At the end of the operation, a skin biopsy was also obtained.
The p ostoperative p eriod w as u neventful, a nd repeated electrocardiograms (ECGs) did not show any change. A pathological examination of the skin showed elastic fiber fragmentation and dystrophic calcium depositions (Figure 2).
The patient was discharged at the end of the first postoperative week, and his postoperative first year was also uneventful. At the end of the first year the patient underwent coronary angiography because of non-specific chest pain, and this revealed that all the grafts were patent, and the flow and the diameter of the LIMA was evaluated as normal.
The main controversy in PXE patients with CAD is the choice of grafts for CABG. The involvement of the IMAs allows for surgeons to avoid using these arteries during CABG. However, other reports have concluded that the LIMA could be considered as a useful graft, whereas others strongly recommend preoperative angiographic and operative macroscopic evaluation of the LIMA.[3-5]
In our case, the LIMA was used as a graft in addition to two saphenous veins. The main reasons that led us to use the LIMA were the normal view of the vessel angiographically and macroscopically during the operation and the adequate flow which was measured during the operation. Although the histopathologic examination of the LIMA showed chronic dissection within the media layer, the early and late postoperative course was uneventful, and the LIMA and saphenous veins were patent angiographically at one year postoperatively.
In conclusion, the IMA is still the most significant and valuable graft used in CABG. In patients with PXE, the IMA may be as involved as the other medium-sized arteries, but this should not preclude its use in CABG. After adequate evaluation of the LIMA during coronary angiography and surgery, if it is not stenozed, it may be used as a conduit for coronary revascularization. However, it should be kept in mind that the long-term patency of arterial grafts still remains unknown in these patients.
Declaration of conflicting interests
The authors declared no conflicts of interest with respect
to the authorship and/or publication of this article.
Funding
The authors received no financial support for the
research and/or authorship of this article.
1) Finger RP, Charbel Issa P, Ladewig MS, Götting C, Szliska
C, Scholl HP, et al. Pseudoxanthoma elasticum: genetics,
clinical manifestations and therapeutic approaches. Surv Ophthalmol 2009;54:272-85.
2) Bercovitch L, Terry P. Pseudoxanthoma elasticum 2004. J
Am Acad Dermatol 2004;51:S13-4.
3) Sarraj A, Al Homsi MF, Khouqeer F. Pseudoxanthoma
elasticum of the internal mammary artery. Cardiovasc Surg
1999;7:381-4.